QRXPHARMA LTD (QRX)

The Company is a clinical stage specialty pharmaceutical company focused on developing and commercialising therapies to treat disorders of the central nervous system.

On this page you will find:

Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
QRX	1.200	-0.83%	1.190	1.200	1.190	1.200	1.190	31,399

QRXPHARMA LTD details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	QRX
Securities	ASX Code, Security Description ------------------------------ QRX, Ordinary Fully Paid
Official Listing Date	25 May, 2007
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.qrxpharma.com
Registered Office Address	Level 1, 194 Miller Street, NORTH SYDNEY, NSW, AUSTRALIA, 2060
Head Office Telephone	(02) 9492 8021
Head Office Fax	(02) 8920 0314
Share Registry	LINK MARKET SERVICES LIMITED LEVEL 12, 680 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone	1300 554 474

Directors / Senior Management
Dr Peter Farrell (Chairman, Director) Dr John Holaday (Managing Director, CEO, Director) Mr Peter Campbell (Director) Dr Gary Pace (Director) Mr Michael Quinn (Director) Mr Chris J Campbell (CFO)

Company Secretary	Mr Chris J Campbell
Principal Activities	The Company is a clinical stage specialty pharmaceutical company focused on developing and commercialising therapies to treat disorders of the central nervous system.

QRXPHARMA LTD announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
17/05/2013		FDA sets 17 July 2013 for MOXDUO Advisory Committee Meeting	2	PDF
09/05/2013		Appendix 3B - Exercise of Stock Options	11	PDF
29/04/2013		Appendix 4C - Quarter Ended 31 March 2013	7	PDF
14/03/2013		FDA sets 26 August 2013 as new PDUFA date for MOXDUO NDA	2	PDF
01/03/2013		Investor Presentation Update - March 2013	43	PDF
28/02/2013		QRxPharma Resubmits MOXDUO New Drug Application to the FDA	2	PDF
21/02/2013		Appendix 3B - Option Issue	9	PDF
18/02/2013		Investor Presentation Update - February 2013	43	PDF
18/02/2013		Half Yearly Report and Accounts - 31 December 2012	18	PDF
24/01/2013		Appendix 4C - Quarter Ended 31 December 2012	7	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
22 May 2013	1.210	-1.63%	1.215	1.200	317,018
21 May 2013	1.230	2.5%	1.230	1.200	818,889
20 May 2013	1.200	0%	1.210	1.160	1,032,232
17 May 2013	1.200	6.19%	1.250	1.140	334,348
16 May 2013	1.130	-0.44%	1.140	1.130	105,292

* Volume of shares shown represents only those shares traded on ASX.

QRXPHARMA LTD price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security QRX. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security QRX

Warrants & Structured Products

No warrants & Structured Products are available over the security QRX

ASX CFDs

No Contracts For Differences are available over the security QRX

MyASX: Login | Sign up